Friday, March 15, 2019 1:08:36 PM
The following is bullshit.
They never got to the pre FDA testing stage.
Therapy Cells, Inc. develops and commercializes a technology for tendon repair for the human market. The company has market cap of $584,496. The Company’s technology is used for tissue transplantation to aid in the repair and regeneration of damaged, diseased, torn, or ruptured musculoskeletal cells and organs in the human, as well as to grow pancreatic cells, for treatment of diabetes, cardiac cells for the treatment of heart disease, and other cell types from various other tissues. It currently has negative earnings. The firm was formerly known as Diamond Information Institute, Inc. and changed its name to Therapy Cells, Inc. in May 2011.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM